In the year 2012, its Promoters Harshad Nanubhai Rathod, Vivek Ashok Kumar Patel, Mayur Popatlal Sojitra and Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, with vision to provide health care products that match international quality standards at competitive price. Thus, the foundation of ‘Accretion Pharmaceuticals’ was laid down, which was started as a Partnership Firm under the Partnership Act, 1932 (Partnership Act) in the name and style of ‘M/s Accretion Pharmaceuticals’, pursuant to a deed of partnership dated December 18, 2012. Thereafter, pursuant to a resolution passed by the partners of M/s Accretion Pharmaceuticals on October 16, 2023, the Partnership Firm was converted into a Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of ‘Accretion Pharmaceuticals Limited’ and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.
Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, the company also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. Its business is majorly carried out on principle-to-principle basis with different marketers. Also, the company caters to multiple corporate clients on loan licence and/or contract manufacturing basis.
The company is ISO 9001:2015, ISO 14001:2015 and ISO 22000:2018 certified and is led by an experienced board of directors, and a professional and experienced management team with extensive experience in the pharmaceutical.
Business area of the company
Accretion Pharmaceuticals is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.
Products of the company
Tablet
- Antibiotic, Antibacterial, Antifungal
- Anti- Inflammatory
- Antihistamine, Antiallergics, Antitussives, Anticold.
- Antiulcer and Antacid
- Anti-Diabetic
- Cardiac and Anti-Hypertensive
- Psychotropic
- Vitamins and Supplement
Capsule
- Antibacterial, Antifungal
- Anti- Inflammatory
- Antiulcer and Antacid
- Cardiac and Anti-Hypertensive
- Vitamins and Supplement
External preparation
- Antibiotic, Antibacterial, Antifungal
- Anti-Inflammatory
- Antipruritic
- Anti-ulcer
- Antiseptic
Oral powder
- Antibiotic, Antibacterial, Antifungal
- Antihistamine, Antiallergics, Antitussives, Anticold
- Antiulcer and Antacid
- Vitamins and Supplement
Oral liquid
- Antibiotic, Antibacterial
- Antihistamine, Antiallergics, Antitussives, Anticold.
- Antiulcer and Antacid
- Vitamins and Supplement
- Antiparasitic, Antiemetic
- Laxative
Awards, accreditations or recognitions
- 2020: Received Indian Achievers Award for Emerging Company in Recognition of Outstanding Professional Achievements & Contribution in Nation Building.
- 2023: Obtained ISO Certification 9001:2015 from the ICV ASSESSMENTS PVT. LTD. for Manufacturer & Exporter of Pharmaceuticals, Nutraceuticals, Ayurvedic, Cosmetics & Wellness Products.
- 2023: Obtained ISO Certification 14001:2015 from the ICV ASSESSMENTS PVT. LTD. for Manufacturer & Exporter of Pharmaceuticals, Nutraceuticals, Ayurvedic, Cosmetics & Wellness Products.
- 2023: Obtained ISO Certification 22000:2018 from the ICV ASSESSMENTS PVT. LTD. for Manufacturer & Exporter of Pharmaceuticals, Nutraceuticals, Ayurvedic, Cosmetics & Wellness Products.
History and milestones
- December 18, 2012: Formed as a Partnership Firm in the name and style of ‘M/s Accretion pharmaceuticals’, pursuant to a deed of partnership dated December 18, 2012.
- November 29, 2023: Incorporation of the Company ‘Accretion Pharmaceuticals Limited” as a Public Limited Company from conversion of ‘M/s Accretion Pharmaceuticals’ a Partnership firm vide partner’s resolution dated October 16, 2023.